Thompson Street Capital Partners, a private equity firm based in St. Louis, has made a growth investment in OpenClinica, an e-clinical platform that looks to drive clinical research by allowing users to automatically capture data from electronic health records while integrating existing clinical workflows.

Headquartered in Waltham, Mass., OpenClinica uses cloud technology for running clinical trials. For over 15 years, OpenClinica has provided electronic data capture, e-source, randomization and analytics and reporting services, among other offerings. The company serves biopharmaceutical companies, contract research organizations, academic institutions and government agencies.

“In conjunction with our leadership team, TSCP’s considerable experience in life science and technology will be incredibly beneficial in helping deliver greater value to customers, and help us grow our Unite network,” states Ben Baumann, co-founder and COO of OpenClinica. “Our cloud-based platform provides innovative, customizable solutions to meet the needs of the entire clinical research ecosystem, and we’re excited to continue providing the features and functionality that makes their work easier and ultimately more impactful.”